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Anaesthesia is the corner stone of modern surgical medicine. Despite a long pe-
riod of enquire beginning with Snow (1847) anaesthesia remains a field in which
there are more questions than answers. This thesis reports findings on three
different aspects of anaesthesia.
1. Initially, a method for calculating a population pharmacokinetic model for
propofol infusion is described. This method greatly reduced the time required
to calculate the model (0.1 seconds per iteration) compared to the NONMEM
method (hours per iteration (Minto, Schnider, Egan, Youngs, Lemmens, Gam-
bus, Billard, Hoke, Moore, Hermann, Muir, Mandema & Shafer 1997)). The
resultant model achieved improved fit to the data than the model of Schu¨ttler
& Ihmsen (2000b) achieving a mean squared error of 0.2835 compared to 0.6413
respectively.
2. Second, a neural network (NN) method is presented to assess Depth of Anaes-
thesia from long segments of raw EEG. The proposed method was able to ap-
proximate the output from a BIS XP monitor for the training data. The linear
regression, between the NN and the BIS monitor, resulted in an R value of
0.99963. The network was able to approximate the BIS monitor output for new
(unseen) data.
3. Finally, a lumped parameter neural mass, anaesthesia, model is presented.
This model is capable of generating changes in EEG associated with increas-
ing doses of γ-aminobutyric acid type A (GABAA) hypnotic agent (propofol).
This model was not a fitting exercise rather it was constructed based on known
brain physiology, and the changes to α1 GABAA receptors conductance caused
by propofol. Encompassing the regional interactions, that are thought to be,
altered by GABA hypnotic agents.
The model is capable of producing five distinct EEG patterns (β, α, θ, δ and iso-
electric) in response to different levels of hypnotic agent. The model is reactive
capable of switching from α to β band EEG when the eyes open. Anaesthetic
supresses the models transition to a higher state EEG.
The model suggest that the effect site for propofol as α1 GABAA receptors of
slow interneurons of the cortex.
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